Azar FM, Andrews JR, Wilk KE, Groh D Operative treatment of ulnar collateral ligament injuries of the elbow in athletes. Am J Sports Med. 2000 Jan-Feb;28(1):16-23.
Bruce JR, Andrews JR Ulnar collateral ligament injuries in the throwing athlete. J Am Acad Orthop Surg. 2014 May;22(5):315-25. doi: 10.5435/JAAOS-22-05-315. Review.
Bruce JR, Hess R, Joyner P, Andrews JR How much valgus instability can be expected with ulnar collateral ligament (UCL) injuries? A review of 273 baseball players with UCL injuries. J Shoulder Elbow Surg. 2014 Oct;23(10):1521-6. doi: 10.1016/j.jse.2014.05.015.
Costantino C, Vaienti E, Pogliacomi F Evaluation of the peak torque, total work, average power of flexor-estensor and prono-supinator muscles of the elbow in baseball players. Acta Biomed. 2003 Aug;74(2):88-92.
Davidson PA, Pink M, Perry J, Jobe FW Functional anatomy of the flexor pronator muscle group in relation to the medial collateral ligament of the elbow. Am J Sports Med. 1995 Mar-Apr;23(2):245-50.
Erickson BJ, Chalmers PN, Bush-Joseph CA, Verma NN, Romeo AA Ulnar Collateral Ligament Reconstruction of the Elbow: A Systematic Review of the Literature. Orthop J Sports Med. 2015 Dec 9;3(12):2325967115618914. doi: 10.1177/2325967115618914. eCollection 2015 Dec.
Hamilton CD, Glousman RE, Jobe FW, Brault J, Pink M, Perry J Dynamic stability of the elbow: electromyographic analysis of the flexor pronator group and the extensor group in pitchers with valgus instability. J Shoulder Elbow Surg. 1996 Sep-Oct;5(5):347-54.
Haugstvedt JR, Berger RA, Berglund LJ A mechanical study of the moment-forces of the supinators and pronators of the forearm. Acta Orthop Scand. 2001 Dec;72(6):629-34.
Keller RA, Steffes MJ, Zhuo D, Bey MJ, Moutzouros V The effects of medial ulnar collateral ligament reconstruction on Major League pitching performance. J Shoulder Elbow Surg. 2014 Nov;23(11):1591-8. doi: 10.1016/j.jse.2014.06.033. Epub 2014 Aug 31.
Laudner KG, Wilson JT, Meister K Elbow isokinetic strength characteristics among collegiate baseball players. Phys Ther Sport. 2012 May;13(2):97-100. doi: 10.1016/j.ptsp.2011.06.007. Epub 2011 Aug 24.
Morrey BF, Tanaka S, An KN Valgus stability of the elbow. A definition of primary and secondary constraints. Clin Orthop Relat Res. 1991 Apr;(265):187-95.
Otoshi K, Kikuchi S, Shishido H, Konno S The proximal origins of the flexor-pronator muscles and their role in the dynamic stabilization of the elbow joint: an anatomical study. Surg Radiol Anat. 2014 Apr;36(3):289-94. doi: 10.1007/s00276-013-1168-3. Epub 2013 Jul 25.
Park MC, Ahmad CS Dynamic contributions of the flexor-pronator mass to elbow valgus stability. J Bone Joint Surg Am. 2004 Oct;86(10):2268-74.
Udall JH, Fitzpatrick MJ, McGarry MH, Leba TB, Lee TQ Effects of flexor-pronator muscle loading on valgus stability of the elbow with an intact, stretched, and resected medial ulnar collateral ligament. J Shoulder Elbow Surg. 2009 Sep-Oct;18(5):773-8. doi: 10.1016/j.jse.2009.03.008. Epub 2009 May 31.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
